PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops

Similar documents
PATIENT INFORMATION LEAFLET

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM RELESTAT, epinastine hydrochloride 0,5 mg/ml, eye drops

PATIENT INFORMATION LEAFLET

PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)

PATIENT INFORMATION LEAFLET

LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml)

Package leaflet: Information for the user. GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution Bimatoprost/timolol

Package leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM OZURDEX, dexamethasone 700 μg intravitreal implant

Package leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride

Package leaflet: Information for the user. GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution, in single-dose container Bimatoprost/timolol

Dorzolamide 20 mg/ml Eye Drops, Solution

Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin

APO-Latanoprost Contains the active ingredient latanoprost

Pilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride

Package leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac

Package leaflet: Information for the patient. Brimonidine Biogaran 2 mg/ml eye drops, solution. brimonidine tartrate

APO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride)

Package leaflet: Information for the patient. IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin

Package Leaflet: Information for the user. NEVANAC 3 mg/ml eye drops, suspension nepafenac

ZADITEN Eye Drops 1.0%

Package leaflet: Information for the user. Carmellose sodium

Package leaflet: Information for the user. Xalatan 50 micrograms/ml Eye drops, solution Latanoprost

PATIENT INFORMATION LEAFLET

NEVANAC TM 0.1% Eye Drops

Package leaflet: Information for the user. <product name> 3 mg/ml eye drops, solution. Ofloxacin

BrinzoQuin Eye Drops 1.0%

ALPHAGAN EYE DROPS BRIMONIDINE TARTRATE

Package leaflet: Information for the user. Latanoprost Pfizer 50 micrograms/ml Eye drops, solution Latanoprost

MAXIDEX Eye Drops 0.1%

What Maxitrol Eye Drops is used for

Package leaflet: Information for the patient. Verkazia 1 mg/ml eye drops emulsion ciclosporin

TIMALEN 0.5% eye drops

PATIENT INFORMATION LEAFLET FOR TEXA 10 mg TABLETS AND TEXA SYRUP PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM:

TOBREX TM EYE DROPS and EYE OINTMENT 0.3%

CILOXAN TM Eye Drops 0.3%

ACULAR EYE DROPS 5 mg/ml Eye Drops

Package Leaflet - Information for the User. TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone

Read this entire leaflet carefully before you start taking DYNA BEZAFIBRATE. If you have further questions, please ask your doctor or your pharmacist.

TRAVATAN Eye Drops 0.004% travoprost

TOBRADEX TM Eye Drops

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. XIIDRA TM* Lifitegrast Ophthalmic Solution 5%

This indication includes the temporary relief of burning, irritation, and/or discomfort due to dryness of the eye.

PATIENT INFORMATION LEAFLET: Lancap 15 mg and 30 mg. Please read this leaflet carefully before taking LANCAP capsules.

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

Package leaflet: Information for the patient. Xemacort 20 mg/g + 1 mg/g cream (fusidic acid and betamethasone)

Package leaflet: Information for the patient. Latanoprost 50 micrograms/ml eye drops, solution latanoprost

TENOPT timolol maleate

MURINE HAYFEVER RELIEF 2% W/V EYE DROPS Sodium Cromoglicate

PATIENT INFORMATION LEAFLET TEXAMER

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP

Package leaflet: Information for the user XATABLOC. 50 micrograms/ml + 5 mg/ml eye drops, solution latanoprost / timolol

IOPIDINE 5mg/ml Eye Drops, solution contain apraclonidine (as hydrochloride) as the active substance.

PATIENT INFORMATION LEAFLET SIMVACOR RANGE

VOLTAREN OPHTHA Eye Drops 0.1%

POLLENTYME S and Tabs Pharma Dynamics (Pty) Ltd Version: July 2017 (G1639) Word copy of G1639 PATIENT INFORMATION LEAFLET FOR POLLENTYME S AND TABS

ISOPTO CARPINE Eye Drops

ENIDIN EYE DROPS [brimonidine tartrate]

Package leaflet: Information for the patient BETAXOLOL 0.5% EYE DROPS. Betaxolol (as hydrochloride)

PATIENT INFORMATION LEAFLET POLLENTYME S AND TABS

AZOPT EYE DROPS 1% What is in this leaflet. Before you use Azopt. What Azopt is used for. Brinzolamide. Consumer Medicine Information.

ILUVIEN 190 micrograms intravitreal implant in applicator (fluocinolone acetonide)

SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM

PATIENT INFORMATION LEAFLET ZOXADON TABLETS RANGE

DUOTRAV Eye Drops travoprost 0.004% and timolol 0.5% Consumer Medicine Information

PRESCRIBING INFORMATION

MAXIDEX TM Eye Ointment 0.1%

Package leaflet: Information for the user. AZOPT 10 mg/ml eye drops, suspension Brinzolamide

PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: Read this entire leaflet carefully before you start taking DYNAFLOC.

Package leaflet: Information for the user. Optilamid 10 mg/ml, oogdruppels, suspensie Brinzolamide

DUOTRAV Eye Drops travoprost 0.004% and timolol 0.5%

Package leaflet: Information for the patient. Brinzolamide 10 mg/ml Eye Drops, Suspension brinzolamide

PATIENT INFORMATION LEAFLET

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. T-LO Timolol Ophthalmic Solution (0.25%, 0.

Package leaflet: Information for the user

Package leaflet: Information for the user. Catacrom 2 % w/v Eye Drops, Solution. Sodium cromoglicate

Package leaflet: information for the user. OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone

CIPROXIN HC Ear Drops

CONSUMER INFORMATION. Sandoz Travoprost / Timolol PQ ophthalmic solution travoprost and timolol ophthalmic solution with POLYQUAD * as preservative

CONSUMER MEDICINE INFORMATION

Package leaflet: Information for the user. COMBIGAN 2 mg/ml + 5 mg/ml eye drops, solution Brimonidine tartrate and timolol

Before prescribing DUOTRAV Eye Drops for you, your doctor will have examined the eye and decided that DUOTRAV Eye Drops is the right medicine.

PATIENT INFORMATION LEAFLET PEPLOC RANGE

Do not use Allergo-COMOD eye drops - if you are hypersensitive against sodium cromoglicate (Ph. Eur.) or one of the other ingredients.

CILOXAN 0.3% Ear Drops

Zovirax Ophthalmic (eye) Ointment Acyclovir

MAXITROL Eye Ointment

PATIENT INFORMATION LEAFLET DYNARB RANGE

IOPIDINE Eye Drops 0.5%

Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine

2 What you need to know before you use Beconase. Package Leaflet: Information for the user

Package leaflet: Information for the user. Bupivacaine 0.25% w/v, 0.5% w/v solution for injection Bupivacaine Hydrochloride

INDICATIONS ACULAR 0,4% ophthalmic solution is indicated for the reduction of ocular pain and burning/stinging following corneal refractive surgery.

Proposed PIL NL/H/0653/001/IB/024/G. MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution in single-dose container Dexamethasone phosphate

PATIENT INFORMATION LEAFLET AMLOC RANGE

Package leaflet: Information for the user. Elaprase 2 mg/ml concentrate for solution for infusion idursulfase

Transcription:

Page 1 of 6 SCHEDULING STATUS Schedule 4 PATIENT INFORMATION LEAFLET PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops Read all of this leaflet carefully before you start using LUMIGAN 0,01 % Keep this leaflet. You may need to read it again. If you have further questions, please ask your doctor or your pharmacist. LUMIGAN 0,01 % has been prescribed for you personally and you should not share your medicine with other people. It may harm them, even if their symptoms are the same as yours. 1. WHAT LUMIGAN 0,01 % CONTAINS Active ingredient: Bimatoprost Inactive ingredients: Benzalkonium chloride 0,02 % m/v (a preservative), sodium chloride, sodium phosphate dibasic heptahydrate, citric acid monohydrate and purified water. Small amounts of hydrochloric acid or sodium hydroxide may be added to bring the solution to the correct ph level. 2. WHAT LUMIGAN 0,01 % IS USED FOR LUMIGAN 0,01 % is prescribed to control glaucoma, which is high pressure in the eye. Bimatoprost belongs to a group of medicines called prostamides. Your eye contains a clear, watery liquid that feeds the inside of the eye. Liquid is constantly being drained out of the eye and new liquid is made to replace it. If the liquid cannot drain out quickly enough, the pressure inside the eye builds up and could eventually damage your sight. LUMIGAN 0,01 % works by increasing the amount of liquid that is drained. This reduces the pressure inside the eye. 3. BEFORE YOU USE LUMIGAN 0,01 % Do not use LUMIGAN 0,01 % If you are hypersensitive (allergic) to bimatoprost or any of the other ingredients of LUMIGAN 0,01 %. Take special care with LUMIGAN 0,01 % Before you use LUMIGAN 0,01 %, tell your doctor: If you have any breathing problems; If you have or have had low blood pressure or low heart rate;

Page 2 of 6 If you have any liver or kidney problems; If you have had cataract surgery in the past; If you have or have had any problems with your cornea (front transparent part of the eye); If you have had a viral infection, inflammation of the eye or any other eye condition; If you are already using a medicine for glaucoma; If you wear contact lenses (see Important information about some of the ingredients of LUMIGAN 0,01 % ). LUMIGAN 0,01 % may cause your eyelashes to darken and grow and cause the skin around the eyelid to darken too. The colour of your iris may also go darker over time. These changes may be permanent. The change may be more noticeable if you are only treating one eye. Hair may grow in areas where LUMIGAN 0,01 % solution has been repeatedly in contact with the skin surface. This is why it is important to apply LUMIGAN 0,01 % as instructed and to avoid it running onto the cheek or other skin areas. LUMIGAN 0,01 % should not be used in people under 18. Pregnancy and breast-feeding Always tell your healthcare provider if you are taking any other medicine. If you are pregnant or breast-feeding your baby, please consult your healthcare provider for advice before using LUMIGAN 0,01 %. LUMIGAN 0,01 % should not be used during pregnancy. LUMIGAN 0,01 % should not be used if you are breast-feeding. Driving and using machinery Your sight may become blurred for a short time just after using LUMIGAN 0,01 %. You should not drive or use machines until your sight is clear again. Important information about some of the ingredients of LUMIGAN 0,01 % Contact lenses should be removed prior to using LUMIGAN 0,01 % in the eyes and may be reinserted 15 minutes following use of the eye drops. LUMIGAN 0,01 % should not be administered while wearing contact lenses. A preservative in LUMIGAN 0,01 % called benzalkonium chloride may cause eye irritation and can discolour soft contact lenses. Using other medicines with LUMIGAN 0,01 % Always tell your healthcare professional if you are taking any other medicines. (This includes complementary or traditional medicines.)

Page 3 of 6 If you use LUMIGAN 0,01 % with another eye medicine, leave at least 5 minutes between putting in LUMIGAN 0,01 % and the other medicine. 4. HOW TO USE LUMIGAN 0,01 % Do not share medicines prescribed for you with any other person. Always use LUMIGAN 0,01 % exactly as your doctor has instructed you. You should check with your doctor if you are unsure. If you have the impression that the effect of LUMIGAN 0,01 % is too strong or too weak, talk to your doctor or pharmacist. The usual dose is one drop in the evening in each eye that needs treatment. Instructions for use You must not use the bottle if the tamper-proof seal on the bottle neck is broken before you first use it. 1. Wash your hands. Tilt your head back and look at the ceiling. 2. Gently pull down the lower eyelid until there is a small pocket. 3. Turn the bottle upside down and squeeze it to release one drop into each eye that needs treatment. 4. Let go of the lower lid, and close your eye for 30 seconds. If a drop misses your eye, try again. Wipe off any excess that runs down the cheek. To avoid contamination, do not let the tip of the bottle touch your eye or anything else. Put the cap back on and close the bottle straight after you have used it. If you use more LUMIGAN 0,01 % than you should It you use more LUMIGAN 0,01 % than you should, it is unlikely to cause you any serious harm. Put your next dose in at the usual time. If you are worried, talk to your doctor or pharmacist.

Page 4 of 6 In the event of over-dosage, consult your doctor or pharmacist. If neither is available, contact the nearest hospital or poison control centre. If you forget to use LUMIGAN 0,01 % Do not use a double dose to make up for the forgotten individual doses. Use a single drop as soon as you remember, and then go back to your regular routine. If you have trouble remembering when to use your medicine, ask your pharmacist for some hints. Effects when treatment with LUMIGAN 0,01 % is stopped LUMIGAN 0,01 % should be used every day to work properly. 5. POSSIBLE SIDE EFFECTS LUMIGAN 0,01 % can have side effects. Not all side effects reported for LUMIGAN 0,01 % are included in this leaflet. Should your general health worsen, or if you experience any untoward effects while using LUMIGAN 0,01 %, please consult your healthcare provider for advice. The following side effects may be seen with LUMIGAN 0,01 %: Affecting the eye Frequent: Eye redness, eye irritation, itchy eyes, redness and/or itching of the eyelids, small breaks in the surface of the eye with or without inflammation, longer eyelashes, irritation when the drop is put in the eye Less frequent: Tired eye, swelling and/or disorder of the conjunctiva (see through layer that covers the eye), crusting on the edge of the eyelid, loss of eyelashes, blurred vision Frequency unknown: Darker eyelid colour, dry eyes, sticky eye, eye swelling, eyelid swelling, eye pain, a feeling of something in the eye, darker eye (iris) colour, tears, changes around the eyes and eyelids such as eyes appearing sunken or eyelid shrinking and moving away from the surface of the eye, macular swelling (swelling of the retina at the back of the eye which may lead to worsening vision) Affecting the skin Frequent: Abnormal hair growth around the eye, darker skin colour Less frequent: Itching of skin Affecting the body Less frequent: Feeling of sickness (nausea) Frequency unknown: Symptoms of allergic reaction (swelling, redness of the eye and rash of the skin), headache, asthma, worsening of asthma, shortness of breath In addition to the side effects for LUMIGAN 0,01 %, the following side effects have been

Page 5 of 6 seen with another medicine containing a higher strength of bimatoprost (0,03 %): Affecting the eye An allergic reaction in the eye, inflamed eyelids, eyelid twitching, cataract (clouding of the lens inside the eye), corneal erosion (disorder of the clear layer at the front of the eye), cystoid macular oedema (swelling of the retina within the eye leading to worsening vision), darker eyelashes, inflammation within the eye, eye burning, sensitivity to light, darker skin colour around the eye, retinal bleeding (bleeding at the back of the eye), difficulty in seeing clearly, worsening of vision, skin redness around the eye Affecting the skin Abnormal or excessive hair growth Affecting the body Dizziness, colds and upper airway infections, abnormal liver function tests, increased blood pressure, weakness, peripheral oedema (swelling in the arms and legs) If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist. 6. STORING AND DISPOSING OF LUMIGAN 0,01 % Store at or below 25 ºC. Store all medicines out of reach of children. Do not use the eye drops after the expiry date printed on the carton and bottle. Once opened, solutions may become contaminated, which can cause eye infections. Therefore, you must throw away the bottle 4 weeks (30 days) after you first opened it, even if some solution is left. To help you remember, write down the date that you opened it in the space on the carton. Keep bottle tightly closed when you are not using it. Return all unused medicine to your pharmacist. Do not dispose of unused medicine in drains and sewerage systems (e.g. toilets). 7. PRESENTATION OF LUMIGAN 0,01 % 2,5 ml filled in 5 ml; 5 ml and 7,5 ml filled in 10 ml white opaque low density polyethylene bottles with a turquoise polystyrene screw cap. Each bottle is packed into an outer carton. 8. IDENTIFICATION OF LUMIGAN 0,01 % Clear colourless solution with no foreign particles. 9. REGISTRATION NUMBER 42/15.4/0835

Page 6 of 6 10. NAME AND ADDRESS OF REGISTRATION HOLDER 30 New Road (entrance off Bavaria Road) Randjespark Ext. 11, Midrand, 1682 Johannesburg, Gauteng SOUTH AFRICA Tel. 011 545 6600 11. DATE OF PUBLICATION Date of registration: 25 November 2011 Date of revision of the most recently revised Patient Information Leaflet as approved by Council: 25 November 2011